Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Stroke Meet 2018

About Stroke Meet 2018

We take immense pleasure in inviting all the participants from all over the world to attend the Neuroscience conference entitled “5th Annual Conference on Stroke and Neurological disorders ” to be held on October 22-23, 2018 in Istanbul, Turkey

Stroke Meet 2018 has been planning and aiming to stimulate new techniques for treatment of Stroke and Neurological disorders that would be beneficial for the neurosurgery and other neurological issues.

The conference will be coordinated around the theme ‘Building a Better World without Disorders’.

Our goal is to bring together worldwide distinguished academics in the field of Neurology and Brain to exchange and share meaningful experiences of various treatment procedures for Neurological disorders and Stroke.

 

Scope and Importance

While more people are surviving strokes, many still face long-term disability. Stroke Meet 2018 provides a platform for all the Neurology professionals, Researchers and Scientists to share knowledge and overcome this disorder by Innovative and Nobel ideas in Diagnosis and Treatment.

 

Target Audience

  • Neurologists and Researchers
  • Neurology Faculty and Students
  • Doctors and Scientists
  • Universities, Associations and Societies
  • Students and Research Scholars
  • Business Delegates
  • Product Manufacturer

 

 

Sessions/Tracks

Track 1: Neurological Disorder

A neurological issue is any turmoil of the sensory system. Basic, biochemical or electrical irregularities in the mind, spinal line or different nerves can bring about a scope of manifestations. Cases of manifestations incorporate loss of motion, muscle shortcoming, poor coordination, and loss of sensation, seizures, perplexity, torment and adjusted levels of cognizance. There are more than 600 neurologic infections. Some of the time they can come about because of biochemical causes also. The pervasiveness rates of the range of neurological issue from various locales of the nation extended from 967-4,070 with a mean of 2394 for every 100000 populaces, giving an unpleasant gauge of more than 30 million individuals with a neurological issue (barring Neuro-infections and traumatic wounds). Commonness and rate rates of the normal issue including epilepsy, stroke, Parkinson's ailment and tremors decided through populace based studies indicate extensive variety crosswise over various districts of the nation. The requirement for an institutionalized screening poll, uniform philosophy for case ascertainment and determination is a fundamental essential for creating strong national information on a neurological issue. Higher rates of pervasiveness of neurological issue in provincial ranges, 6-8 million individuals with epilepsy and high case casualty rates of stroke (27-42%) call for pressing procedures to set up effort neurology administrations to take into account remote and country regions, create National Epilepsy Control Program and set up stroke units at various levels of social insurance pyramid.

Track 2: Stroke and its Management

A stroke is a restorative crisis. Strokes happen when bloodstream to your mind stops. Inside minutes, cerebrum cells start to kick the bucket. There are two sorts of stroke. The more normal kind, called ischemic stroke, is created by a blood coagulation that squares or attachments in a vein in the cerebrum. The other kind, called hemorrhagic stroke, is brought on by a vein that breaks and seeps into the cerebrum. "Smaller than normal strokes" or transient ischemic assaults (TIAs), happen when the blood supply to the cerebrum quickly interferes. Stroke is the third driving reason for death in the United States. Of the more than 700,000 individuals influenced each year, around 500,000 of these are first assaults, and 200,000 are intermittent. Around 25 percent of individuals who recuperate from their first stroke will have another stroke inside five years. Stroke is the main source of genuine long haul handicap, with an expected 5.4 million stroke survivors presently alive today.

Track 3: Mental Health:  Alzheimer’s and Dementia

A stroke is an emergency of medical aspect that requires early treatment that indicates an early action can minimize brain damage and potential complications. A person affected by stroke addresses cognition and/or behavioral problems that include problems using languages, vision and perception problems and sudden bursts of emotions.

Dementia and Alzheimer’s disease aren’t the same. Dementia is an overall term used to describe symptoms that impact memory, the performance of daily activities, and communication abilities. Alzheimer’s disease is the most common type of dementia. Alzheimer’s disease gets worse with time and affects memory, language, and thought. Dementia is a syndrome, not a disease. A syndrome is a group of symptoms that don’t have a definitive diagnosis. Dementia is a group of symptoms that affect mental cognitive tasks such as memory and reasoning. Dementia is an umbrella term that Alzheimer’s disease can fall under. It can occur due to a variety of conditions, the most common of which is Alzheimer’s disease.

Track 4: Stroke Rehabilitation and Brain Hemorrhage

The long-term goal of rehabilitation is to improve function so that the stroke survivor can become as independent as possible. This must be accomplished in a way that preserves dignity and motivates the survivor to relearn basic skills that the stroke may have impaired - skills like bathing, eating, dressing and walking. Rehabilitation starts in the hospital as soon as possible following a stroke. The rehab team includes Physiatrist, Neurologist, Rehabilitation Nurse, Physical Therapist, Occupational Therapist and Speech-Language Pathologists. Cerebrovascular refers to blood flow in the brain. Arteries supplying oxygen to the brain are affected and bring about one of a number of cerebrovascular diseases. Most common is a stroke or mini-stroke and sometimes can be a hemorrhagic stroke. Cerebrovascular diseases include carotid stenosis, vertebral stenosis and intracranial stenosis, aneurysms, and vascular malformations. Restriction in blood flow can be caused by vessel narrowing, clot formation, blockage or blood vessel rupture.

It is estimated that about 6 million deaths are due to cerebrovascular disorders. It is the second leading cause of death in the world and 6th most common cause of disability.

Track 5: Neurophysiology and Neurodegeneration

Neuroscience is a branch of study that deals with the anatomy, biochemistry, molecular biology, and physiology of neurons and neural circuits. The scope of neuroscience has broadened over time to include different approaches used to study the molecular, cellular, developmental, structural, functional, evolutionary, computational, psychosocial and medical aspects of the nervous system. The tools used for imaging Nerve are Positron Emission Tomography (PET), Diffusion Tensor imaging (DTI), Magnetic Resonance Neurography (MRN), Computerized Tomography (CT), and Plain X-Ray. MRN is the advanced technology used to image Peripheral Nerve for the diagnosis of any disorder in the Nerves and Neuromuscular Diseases. It can image any Nerves in the body and are commonly used for the diagnosis of the Nerve disorder in Brachial Plexus.

Track 6: Brain Tumors and Neuro-Oncology

Essential cerebrum tumors can be either harmful (contain growth cells) or considerate (don't contain cells). An essential mind tumor is a tumor which starts in the cerebrum. In the event that a destructive tumor which begins somewhere else in the body sends cells which wind up developing in the cerebrum, such tumors are then called optional or metastatic mind tumors. This talk is centered on essential cerebrum tumors. Mind tumors can happen at any age. The correct reason for cerebrum tumors is not clear. The manifestations of cerebrum tumors rely on upon their size, sort, and area. The most widely recognized side effects of mind tumors incorporate cerebral pains; deadness or shivering in the arms or legs; seizures, memory issues; the state of mind and identity changes; adjust and strolling issues; sickness and regurgitating; changes in discourse, vision, or hearing.

Track 7: Neuropsychiatry

Neuropsychiatry is the interface of Psychiatry and Neurology that deals with mental disorders, which in most cases can be shown to have their origin from an identifiable brain malfunction. It can also be defined as a sub-specialty of Psychiatry, focusing to understand the link between the mind, body and its behavior. Training in both organic (neurological) and psychiatric aspects of illness places Neuropsychiatry in a unique position to deliver this care. An effective evaluation of the clinical course of diseases requires the application of very precise diagnostic and assessment approaches as early as possible. By achieving these strategies, offers new opportunities for biomarker identification and/or discovery in complex diseases and may provide pathological pathways understanding for diseases beyond traditional methodologies.

Track 8: Stroke Nursing and Interventions

Nurses play a pivotal role in all phases of care of the stroke patient. Some of the nurse caring plans are Ineffective Cerebral Tissue Perfusion, Impaired Physical Mobility, Impaired Verbal Communication, Disturbed Sensory Perception, Ineffective Coping, Self-Care Deficit, and Risk for Impaired Swallowing. Nurses may work as an emergency medical technician (EMT) and paramedics, radio providers of online medical control to emergency medical services (EMS) personnel from base stations, and educators who teach EMS personnel about stroke and the care of stroke patients. Nurse Interventions are monitoring major signs in patients such as monitoring blood pressure, comparing BP reading in arms, heart rate, rhythm, and murmurs. There also monitor Respirations, noting patterns and rhythm, Cheyne-Stokes respiration.

Track 9: Neuroplasticity and Blood-Brain Barrier

There are about 600 Neurological disorders and approximately 50 million Americans are being affected each year. The main risk factors for Neurological disorders are genetic manipulation, age, lifestyle and other environmental agents. Abnormalities in structural and biochemical functions cause various symptoms. Some of them are paralysis, seizures, confusion, muscle weakness and altered levels of consciousness.

The ability of the Brain to alter at any age is referred to as Neuroplasticity or Brain Plasticity. The recent neuroscience research proves that Neuroplasticity is the basis for brain training exercises which revolutionized the brain health and science research.

Track 10: Pediatric Stroke and Recovery

Stroke is the main cause of death in children in the USA and the most pediatric stroke survivors will be suffering from neurological or cognitive impairments. Because of the plasticity of the brains of children, they recover faster than adults. A stroke survivor may be diagnosed with Epilepsy. Based on the cause of the stroke, the treatments will be decided by the physicians. Constraint therapy is an old therapy, but it is now extensively used in the pediatric stroke rehabilitation. If the stroke is caused by the blockage, then blood thinning medications will be given. If stroke happens due to Sickle Cell Disease (SCD), then an immediate blood transfusion will be performed. A physiotherapist can help with movement problems such as weakness or paralysis, spasticity (a stiffness that develops in the muscles after stroke) or muscle spasms.  The therapist will assess and design a program to improve muscle strength (which can reduce the risk of spasticity) and movement.

It is estimated that about 6 million deaths are due to cerebrovascular disorders. It is the second leading cause of death in the world and 6th most common cause of disability.

Track 11: Clinical Trials in Neurology

Clinical trials and research are an important part of the Department of Neurology. This clinical trial will lead to the new discovery that eventually improves the patient health. Clinical trials allow researchers to study new treatment options, drugs or combinations of treatments to determine if they can be integrated into a standard practice of care. A list of active clinical trials is provided below. Many research trials have been conducted in each department of neurology to ensure the safety and advancement of patient care.

Track 12: Brain Dead and Organ Donation

Brain death occurs when a person has an irreversible, catastrophic brain injury, which causes total cessation of all brain function (the upper brain structure and brain stem). Brain death is not a coma or persistent vegetative state. Brain death is determined in the hospital by one or more physicians not associated with a transplantation team. For the patient with a non-traumatic brain injury like a stroke, there is no outward sign that the patient has suffered a devastating and non-survivable injury to the brain. The patient looks to be asleep, is warm to touch and appears to breathe, albeit with the help of a machine.

Market Analysis

Stroke Meet 2018 welcomes attendees, presenters, and exhibitors from all over the world to Istanbul, Turkey. We are delighted to invite you all to attend and register for 5th Annual Conference on Stroke and Neurological Disorders having the theme “Building a Better World without Disorder” which is going to be held during October 22-23, 2018 at Istanbul, Turkey. 

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Stroke Meet 2018, where you will be sure to have a meaningful experience with scholars from around the world.

Scope and Importance

Stroke Meet 2018 aims to bring together leading academic scientists, researchers, and research scholars to exchange and share their experiences and research results about all aspects such as; Advances in Prevention, Treatment, and Recovery in Stroke and other Neurological disorders. It also provides the premier interdisciplinary forum for researchers, practitioners, and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Stroke and Neurological Disorders.

Neuro disorders are the disorders of brain, spine and nerve cells. It occurs due to the faulty genes and by muscular dystrophy.  Damage to the nerve cell or death of the nerve cell causes degenerative disorders such as Parkinson's disease and Alzheimer's disease. Diseases of the blood vessels that supply the brain, include stroke, Injuries to the spinal cord and brain Seizure disorders, such as epilepsy Cancer etc.  The persons suffering from Neuro disorders have poor judgment, relapsing of memory, Tremor, Loss of automatic movement, Speech changes, rigid muscle etc. So this conference will provide novel technologies in the development of Neurology and neuro disorders.

Report Highlights

  • The global market for neurological disease treatment and medication was worth $12.6 billion in 2006 and reached $14 billion by 2007. At a compound annual growth rate (CAGR) of 11.6%, the global market will be worth almost $42.3 billion by 2022.
  • Drugs for multiple sclerosis, Alzheimer's disease, and Parkinson's disease control approximately 99% of the total market share.
  • Medications for multiple sclerosis are just over 35% greater than the market share of medication for Alzheimer's disease, despite the fact that there are far fewer patients with MS. As AD drugs become more prevalent, the shares of the market could change dramatically.

 

Top Neurology Universities in Globe:

  • Leiden University
  • Keele University
  • Plymouth University
  • University of Toledo
  • University of Sheffield
  • University of Birmingham
  • University of Windsor
  • University of Edinburgh
  • University of California Irvine
  • University of Nottingham
  • New York University

 

Related Conferences:

 

Associations:

USA

American Stroke Association | National Stroke Association | Heart and Stroke Foundation of Canada | North Carolina Stroke Association | American Association of Neurological Surgeons | American Academy of Neurology | Canadian Stroke Consortium | Canadian Stroke Network | Intermountain Stroke Center | National Stroke Association

Europe:

German Stroke Society | European Stroke Organization | World Federation of Neurology | World Stroke Organization | The Brain Injury Association | Mediterranean Stroke Society | European Federation of Neurological Associations | Spanish Society of Neurology | European neurological society | European Academy of Neurology | National Stroke Association of Russian Federation | Central and East European Stroke Society | Romanian National Stroke Association (RNSA)

Asia:

Japanese Circulation Society | Singapore National Stroke Association (SNSA) | Chinese Stroke Association| Pacific Stroke Association | Indian Stroke Association | Chinese Society of Neurology | Japan Stroke Association | Japan Stroke Society | Neurological Association of Thailand/Thai Stroke Society

Past Conference Report

Stroke 2017

3rd International Conference on Neurological Disorders and Stroke was organized during April 24-25, 2017 at JW Marriott Dubai, UAE with the support and contribution of the Organizing Committee Members.

Firstly we must thank you for trusting us and participating at Stroke 2017, a global platform to discuss various important aspects of Neurology.

There are infinite reasons to extend our gratitude to you for making the Stroke 2017 outstanding conference. We couldn't have done it without your continuous support and believe towards our organization, which mutually made to achieve Stroke 2017 new heights in the field of Neuroscience.

The conference was marked by the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 15 countries, who have driven this event into the path of success.   

The conference was organized around the theme “Adaptive treatments and Modern Diagnosis of Neurological Disorders and Stroke”. The event implanted a firm relation of upcoming strategies in the field of Novel approaches and Developments in Neurological Disorders and Stroke with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as Keynote speakers:  Sandro Iannaccone, San Raffaele Hospital, Milan Italy, Joshua K. Underwood, Vermont Academy, USA, Arshad Zaman, The Leeds Teaching Hospitals, Leeds, UK, Wai Kwong Tang, Chinese University of Hong Kong and Rola Aatif Mahmood, Salmaniya Medical Complex, Bahrain.

The conference witnessed an amalgamation of peerless speakers, Keynote speakers, well-known researchers and delegates who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Neurological Disorders and Stroke through their fabulous presentations at the podium of Stroke 2017.   

Conference series LLC offers its heartfelt appreciation to all the Organizing Committee Members, Chairs and Co-chairs, Speakers, Students, Media Partners, sponsors and Editorial Board Members of Journal of Neurology,  Journal of Brain Disorders & Therapy and  Journal of Brain Tumors & Neurooncology who supported the conference in every aspect for the awe-inspiring exhibition at the venue.

So as a continuation of Stroke 2017, we would like to heartily invite you to our upcoming 5th Annual Conference on Stroke and Neurological Disorders to be held in Istanbul, Turkey on October 22-23, 2018

For 2018 we are expanding our focus towards all aspects of Neurological Disorders and Stroke Re­search findings. Our organizing committee is gearing up with more innovative and explorative sessions to unleash the boundaries of the Neurological Disorders and Stroke.

Your expertise and knowledge in the area of Neurological Disorders and Stroke will provide an oppor­tunity to discuss and respond to a series of questions about the status of advanced Neurological Disorders and Stroke therapeutics.

Stroke is ranked as the second leading cause of death in the Dubai. In the Middle East and North Af­rica, stroke is emerging as a major health problem, with the death rate from it will be double by 2030. In 2013 alone, U.A.E. healthcare expenditures reached an estimate of $ 16.8. The healthcare market of the UAE is expected to expand at a CAGR of over 16% during 2011-2014 on back of neurological disorders. About $ 177.5 million revenue generated from medical tourism in 2012, which may rise to $ 710 million by 2020. FDA submitted drug market report on central nervous system disorders which is estimated $78 billion in 2010 and to reach nearly $81.8 billion by 2015. The market survey forecast of neurological disorders is more than $500 billion per year and also the cost of stroke care is expensive too.

We would like to organize this conference with your support to gather all the Neurological Disorders and Stroke researchers in a single platform, hope we will be honored with your support to organize Stroke 2018 in a grand level, your support will be the key of success for our next year conference.

We look forward to seeing your benign presence with active contribution and support to make this event successful once more.

Once again it’s our pleasure to welcome you to our upcoming 5th Annual Conference on Stroke and Neurological Disorders to be held in Istanbul, Turkey on October 22-23, 2018.


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date October 22-23, 2018

For Sponsors & Exhibitors

sponsors@conferenceseries.com

Speaker Opportunity

Supported By

Journal of Neurological Disorders Brain Disorders & Therapy Journal of Tumour Research & Reports

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos